1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. MACROGENICS INC

Macrogenics Inc

XNAS: MGNX

Expensive Underperformer
Download real time

2.10 -0.08 (-3.67%)

New 52W Low in past week

395.3K XNAS Volume

XNAS 20 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
7S
16W
4O
1T
131.8

Market Cap

Below industry Median
-1.4

PE TTM

Negative PE TTM
0

PEG TTM

1.1

Price to Book

Below industry Median
-0.3

Beta 1Year

Very Low volatility
Board Meeting
The board meeting for Macrogenics Inc is scheduled for today, for the purpose of Macrogenics Inc Fourth Quarter Earnings Result for 2024 See details

Macrogenics Inc - MGNX - stock price prediction, stock price target, analyst ratings from 9 analysts

Macrogenics Inc has a share price target of US$ 6, revenue growth forecast of 180.5%, and profit growth estimate of -575.8% for FY24, based on top 9 analyst calls.

Forecaster Screeners